Fibrin sealant, aprotinin, and immune response in children undergoing operations for congenital heart disease.

[1]  H. Wendel,et al.  Anaphylactic shock after aprotinin reexposure: time course of aprotinin-specific antibodies. , 1997, The Annals of thoracic surgery.

[2]  W. Dietrich,et al.  Prevalence of anaphylactic reactions to aprotinin: analysis of two hundred forty-eight reexposures to aprotinin in heart operations. , 1997, The Journal of thoracic and cardiovascular surgery.

[3]  L. Martinelli,et al.  Aprotinin in staged heart transplantation: anaphylactic potential of repeated exposure. , 1996, The Annals of thoracic surgery.

[4]  N. Ciavarella,et al.  Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes. , 1996, Journal of immunology.

[5]  W. Spotnitz.  Fibrin Sealant in the United States: Clinical Use at the University of Virginia , 1995, Thrombosis and Haemostasis.

[6]  M. Abel,et al.  Fatal anaphylactic shock after aprotinin reexposure in cardiac surgery. , 1995, Anesthesia and analgesia.

[7]  J. Pfannschmidt,et al.  Routine intraoperative application of high-dose aprotinin in open heart surgery in adults: antibody formation after first exposure. , 1995, Current medical research and opinion.

[8]  H. Colten.  Drawing a double-edged sword , 1994, Nature.

[9]  R. Shimizu,et al.  An anaphylactic reaction to topical fibrin glue. , 1994, Anesthesiology.

[10]  M. Kimura,et al.  [Anaphylactic reaction to aprotinin following topical use of biological tissue sealant]. , 1994, Masui. The Japanese journal of anesthesiology.

[11]  今紀子.  Anaphylactic reaction to aprotinin following topical use of biological tissue sealant. , 1994 .

[12]  J. Haberer,et al.  Anaphylactic reaction to aprotinin during cardiac surgery , 1993, Anaesthesia.

[13]  G. Occelli,et al.  Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. , 1993, Annales Francaise d'Anesthesie et de Reanimation.

[14]  T. Graeter,et al.  Severe anaphylactic shock due to repeated application of aprotinin in patients following intrathoracic aortic replacement. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  B. Wüthrich,et al.  IgE-mediated anaphylactic reaction to aprotinin during anaesthesia , 1992, The Lancet.

[16]  D. Royston.  High-dose aprotinin therapy: a review of the first five years' experience. , 1992, Journal of cardiothoracic and vascular anesthesia.

[17]  R. Aalberse,et al.  The role of IgG in immediate-type hypersensitivity. , 1991, The European respiratory journal. Supplement.

[18]  D. Cosgrove,et al.  Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). , 1989, The Journal of thoracic and cardiovascular surgery.

[19]  D. Cosgrove,et al.  Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.

[20]  Y. Yanagihara,et al.  Immunological studies on patients who received aprotinin therapy. , 1985, Arerugi = [Allergy].

[21]  K. Ishizaka.  Mast Cell Activation and Mediator Release , 1984 .

[22]  K. Ishizaka,et al.  Activation of mast cells for mediator release through IgE receptors. , 1984, Progress in allergy.

[23]  R. Kleinert.  [Fatal bee sting: 1st report of IgG4-mediated anaphylactic shock]. , 1983, Wiener klinische Wochenschrift.

[24]  A. Haverich,et al.  Clinical Use of Fibrin Adhesive , 1982 .

[25]  H. Dinges,et al.  [Water-tight closure of spinal dura with a new clot suture technique (author's transl)]. , 1978, Wiener klinische Wochenschrift.

[26]  L. Wide,et al.  Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy , 1976, British Journal of Dermatology.